Return
to Green Module for Chemical Toxicology Home
Biochemical Toxicology of Insecticides: The Road Towards Reduced-Risk Insecticides
Timothy D. Foley,
Chemistry
Department,
University
of Scranton
foleyt2@scranton.edu
INTRODUCTION
The use of chemicals to control levels
of crop-damaging insects has helped to increase agricultural efficiency
during the past century. This practice has also been plagued by controversy.
Insecticides have traditionally targeted nervous system functions that
are common to many species including humans. The use of these neurotoxic
insecticides has led to the indiscriminate killing of beneficial insects
and posed a serious risk to other animals and humans from environmental
exposures. Moreover, increasing evidence has suggested a possible
link between human environmental exposures to insecticides and neurological
diseases such as Parkinson's disease (1). Thus, there is a
tremendous need to develop insecticides that display greater target selectivity
and, thus, a reduced risk to non-target species and humans. In recent
years, a novel class of bisacylhydrazine insecticides developed by Rohm
and Haas Company (Philadelphia, PA) have been found to display highly selective
toxicity by interfering with the unique physiology of insect growth.
Two of these compounds have recently been designated as "reduced-risk"
by the Environmental Protection Agency
(EPA). On another front, an understanding of the more subtle biochemical
mechanisms by which low levels of environmental chemicals (xenobiotics)
may increase the risk for developing specific human diseases is rapidly
emerging. This understanding should enhance our ability to screen
for potential adverse health effects that are not readily predicted by
traditional toxicological testing. The following toxicology module
provides an overview of 1) nervous system function, 2) the primary mechanisms
of traditional and bisacylhydrazine insecticidal actionand acute non-target
toxicity, and 3) subcellular mechanisms of xenobiotic action that are distinct
from these mechanisms but that are becoming recognized as relevant to human
disease.
NERVOUS SYSTEM FUNCTION
SYNAPTIC TRANSMISSION
Nervous system function is mediated
largely by the communication between the excitable (i.e., responsive to
changes in ion levels) nerve cell and other excitable cells of an organism
which may be either other neurons or muscle cells (2). Communication
is initiated by the release of chemical messengers called neurotransmitters
from a presynaptic nerve cell. The neurotransmitter diffuses across
synapse (space) between the nerve cell and a contacted (postsynaptic) cell
and binds to a receptor protein on the membrane of that cell (Fig. 1).
Binding stimulates the opening of an ion channel (pore) in the membrane
which facilitates the flux of specific ions (e.g., Na+,
K+, Ca2+,
or Cl-
depending on the channel) across the membrane down their
concentration gradients either into or out of the cell. Neurotransmitters
may be
excitatory orinhibitory depending on how they change the
ionic charge on the inside of the cell which, in the absence of neurotransmitter,
is negative with respect to the outside of the cell. Excitatory neurotransmitters
depolarize
the cell by promoting an influx of Na+
which, in some case, may be accompanied by Ca2+.
This initial depolarization is propagated by the opening of voltage-sensitive
Na+ channels along
the axon (the skinny part) of the nerve cell and ultimately results in
the opening of voltage-sensitive Ca2+
channels in the nerve ending. The influx of Ca2+
stimulates the release of neurotransmitter into the next synapse.
In muscle cells, the influx of Ca2+
stimulates muscle contraction. In contrast to excitatory neurotransmitters,
inhibitory neurotransmitters
hyperpolarize the cell by promoting
either an efflux of K+
ions or an influx of Cl- ions. This makes the cell more
resistant to depolarization, Ca2+
influx, and release of neurotransmitters (in neurons) or contraction (in
muscle cells).
Figure 1. Neurotransmitter Receptor and Ion Channel
MECHANISMS OF ACUTE INSECTICIDE TOXICITY
ORGANOCHLORINES: EXCITOTOXIC
INSECTICIDES
The organochlorine category of insecticides
includes DTT (dichlorodiphenyltrichloroethane), lindane, and the cyclodienes
(e.g., dieldrin, endrin, chlordane, and heptachlor) (3). These
insecticides are generally very lipophilic and are not readily transformed
to more hydrophilic metabolites and excreted. Thus, they are able
to partition into fatty tissues and bioaccumulate. Indeed, DTT may
remain in the body for years. Organochlorine insecticides generally
act by promoting excessive increases in the excitability (i.e., sensitivity
to depolarization) of neurons. This causes rapid and repetitive firing
of neurons which manifests as tremors, hyperexcitability, convulsions,
and eventual paralysis. This mode of neurotoxicity is called excitotoxicity.
The
mechanisms by which DDT, lindane, and the cyclodiene insecticides produce
excitotoxicity are outlined below.
DTT
The lipophilic nature of DTT (Fig.
2) allows it to concentrate in the cell membrane and affect the function
of membrane proteins (e.g., channels, receptors, transporters). The
major mechanism by which DTT acts is thought to be by prolonging the opening
of membrane-bound Na+ channels although it may also modify the function
of several other membrane proteins (3). The effect of DTT
on Na+ channel kinetics is temperature-sensitive and is not observed at
temperatures above about 30 degrees Celsius. This temperature-dependence
is believed to explain why DTT is much more toxic to colder-blooded insects,
fish, and aquatic invertebrates than it is to humans (3).
However, the environmental persistence, bioaccumulation, and non-target
toxicity of DTT, brought to the Nation's attention by Rachel Carson's novel
Silent
Spring, led to DTT being banned for use in the U.S. in 1973 although
human exposures may still result from products imported into the U.S.
Figure 2. DDT
LINDANE and the CYCLODIENES
Lindane is the gamma isomer of hexachlorocyclohexane
(BHC) (3). Cyclodienes are a class of organochlorine insecticides
that are prepared from hexachlorocyclopentadiene by the Diels-Alder and
subsequent reactions (3). They include dieldrin, endrin, chlordane,
and heptachlor. Like DTT, lindane and the cyclodienes are very lipophilic.
They resemble picrotoxin, an antagonist (inhibitor) of a postsynaptic receptor
for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).
The binding of GABA to this receptor, called the GABA-A receptor, stimulates
influx of Cl- ions which hyperpolarizes the cell and makes it more resistant
to depolarization. Thus, these insecticides promote excitotoxicity
by blocking the stimulation of Cl- influx by GABA. Lindane and the
cyclodienes exhibit significant non-target toxicity. They are very
toxic to non-target insects, fish, and birds. The cyclodienes are
also toxic to other mammals.
ORGANOPHOSPHOROUS AND CARBAMATE INSECTICIDES: ACETYLCHOLINESTERASE INHIBITORS
ACETYLCHOLINE and ACETYLCHOLINESTERASE
Acetylcholine is a neurotransmitter
that, upon release from neurons, stimulates the opening of a Na+ and K+
channel that regulates the function of the brain as well as the heart,
lungs, and skeletal muscles (2). Acetylcholine signaling in
the synapse is terminated by an enzyme acetylcholinesterase (AChE) which
catalyzes the hydrolysis of acetylcholine to form inactive acetate and
choline (Fig. 3) (2-4). AChE is a member of the serine esterase
class of enzymes that contain an active site serine (Ser) in addition to
histidine (His) and glutamate (Glu) amino acid residues that cooperate
to catalyze the hydrolysis of acetylcholine. Briefly, H-bonding occurring
between the Glu carboxylate group and the N-1 of the His imidazole ring
enhances the ability of the N-3 of His to act as a base and abstract the
H from the Ser hydroxyl group. This cooperation makes the Ser oxygen
a stronger nucleophile which readily attacks the carbonyl carbon of acetylcholine.
This reaction results in the formation of a tetrahedral intermediate that
is likely stabilized by H-bonding in an "oxyanion hole" (Fig. 4).
The more stable binding of the tetrahedral intermediate than acetylcholine
itself to the enzyme active site is a major reason why AChE is able to
catalyze this reaction. Collapse of the tetrahedral intermediate
and release of choline leaves behind the acyl enzyme. The acyl enzyme
is attacked by a water molecule causing the release of acetate (i.e., by
hydrolysis) and the regeneration of the active site Ser which is now poised
for another catalytic cycle.
Figure 3. Acetylcholinesterase Mechanism
Organophosphorous (e.g., parathion
and malathion) (Fig. 4) and N-methylcarbamate (e.g, carbaryl, aldicarb)
insecticides are believed to act by inhibiting AChE activity (3,4).
They do so by acting as pseudosubstrates and forming a covalent adduct
with the active site Ser. This results in accumulation of acetylcholine
in the synapse, overstimulation of AChE receptors and, ultimately, death
by respiratory failure. Parathion and malathion become much more
potent AChE inhibitors following oxidation in a reaction catalyzed by cytochrome
P450 monooxygenases. Indeed, the sensitivity of an organism to organophosphorous
compounds is greatly determined by the relative rates of oxidative transformation
vs a hydrolytic conversion to less toxic species. Differential metabolism
is believed to underlie the lower sensitivity of mammals to malathion.
Oxidative metabolism replaces sulfur with the more electronegative oxygen.
This increases the positive charge on the phosphorous atom and makes it
more reactive towards the AChE Ser. Moreover, the rate of hydrolysis
of the resulting phosphorylated enzyme is generally so slow that AChE is
likely to be degraded and replaced by a newly synthesized enzyme before
release of phosphate occurs. The replacement of AChE may occur with
a half-life of 10-30 days so that repeated exposures to subtoxic doses
of organophosphates may produce a cumulative response. The N-methylcarbamates
are generally more readily reversible and, thus, less toxic to non-target
organisms since repeated exposures are less likely to produce an additive
effect.
Figure 4. Organophosphorous Insecticides
BISACYLHYDRAZINE INSECTICIDES
(GREEN CHEMISTRY)
In recent years, it has become apparent
that more selective toxicity may be achieved by targeting the unique physiology
of insect growth. The growth of insects is accompanied by the periodic
shedding of their outer cuticle layers, a process called molting.
Molting is initiated by an increase in the levels of the steroid hormone
20-hydroxyecdysone (20E) (Fig. 5) and terminates upon metabolism of 20E
and a decline of 20E concentrations to basal levels (5). 20E
acts by binding to an ecdysteroid receptor protein. The 20E-receptor
complex directly activates the expression of genes that are involved in
the molting process. In 1988, two papers in the journal
Science
reported that the bisacylhydrazine compound RH-5829 (Fig. 6), developed
by scientists at Rohm and Haas Company,
was a metabolically stable ecdysteroid receptor agonist (6,7).
That is, it induced the molting process by apparently binding to the ecdysteroid
receptor like 20E. However, because it is not rapidly metabolized,
the levels of RH-5829 remain high and the target insects are unable to
recover from a RH-5829-induced molt (5-7). They die of dehydration
and/or starvation. Thus, RH-5829 produced a lethal molt by
virtue of both its ecdysteroid agonist activity and metabolic
stability. Since then, other more potent and selective bisacylhydrazine
insecticides such as tebufenozide and halofenozide (Fig. 5) have been developed.
Notably, tebufenozide and halofenozide have been designated "reduced risk"
pesticides by the EPA and, for their development, Rohm and Haas received
a Presidential
Green Chemistry Challenge Award. Indeed, they exhibit a remarkable
target selectivity with little or no toxicity reported for many other beneficial
insects. Specifically, tebufenozide kills caterpillars while halofenozide
kills beetle larvae, cutworms, and webworms.
Figure 5. 20-Hydroxyecdysone and the Bisacylhydrazine Insecticides
The basis for the insecticide selectivity
exhibited by the bisacylhydrazines is not entirely clear since all molting
insects contain 20E and ecdysteroid receptors. Selectivity appears
to be partly attributable to differences in the binding affinity of the
bisacylhydrazines for the ecdysteroid receptors of different insects (5).
It also may involve differences in bisacylhydrazine metabolism and transport
among different species of insects (5). Of course, it is also
plausible that the relatively small differences in binding affinities of
the bisacylhydrazines for the receptors of different insects may reflect
much larger differences in the receptor protein conformation.
The acute toxicity of the bisacylhydrazines
to higher organisms has been reported by Rohm and Haas to be very low (5).
However, they are significantly lipophilic and may affect membrane structure
and function. In fact, they have been reported to produce excitotoxicity
in some insects by partitioning into membranes and blocking K+-channels
(8), a mechanism that appears to be independent of ecdysteroid activity.
Thus, the potential for ecdysteroid-independent toxicity and, indeed, neurotoxicity
should be recognized and further explored. Nonetheless, the bisacylhydrazine
insecticides highlight a novel strategy for developing insecticides with
greater selectivity. Furthermore, they are being used as tools to
further understand the unique biochemistry and physiology of insects which
should identify other molecular targets for insect-selective toxins.
ADDITIONAL CONSIDERATIONS: ENVIRONMENTAL
EXPOSURES AND HUMAN DISEASE
Targeting of the unique physiology
of insects, as demonstrated by the bisacylhydrazine insecticides, represents
a major advancement in the design of reduced-risk insecticides. However,
it is important to recognize that the label of "reduced-risk" generally
refers to a lower risk of gross symptoms of toxicity (e.g., death, convulsions,
tumors, respiratory distress) in animal models (usually rodents) following
acute (immediate) or short-term (< year) exposures. Thus, the
information that can be obtained concerning the relationships between environmental
exposures and human diseases (e.g., cancer, heart disease, and neurological
diseases), which may develop over decades, is very limited. The mechanisms
by which exposure to xenobiotics may increase the risk for developing human
diseases are becoming more apparent and may be very distinct from the mechanisms
of acute toxicity outlined above. Three such mechanisms are outlined
below.
MITOCHONDRIAL DYSFUNCTION
Mitochondria are the sites of electron
transport (Fig. 6) and the coupled synthesis of the major part of ATP produced
in our cells (9). Mitochondrial dysfunction results in lower
ATP production, increased generation of toxic forms of oxygen (e.g., superoxide,
hydrogen peroxide), and, recently, has been implicated as an initiator
of the orchestrated form of cell suicide known as apoptosis (10).
Moreover, increasing evidence supports the notion that aging-related mitochondrial
dysfunction may play an important role in the development of human neurological
disease (10). Thus, findings that a wide range of chemicals,
including insecticides, perturb mitochondrial function have profound implications
for our understanding of potential toxicities and relationships of chemical
exposures to human disease. Indeed, some organophosphorous compounds
including parathion induce changes in mitochondrial membrane permeability
and inhibit mitochondrial function (11). Furthermore, some
chemicals that have been used as insecticides such as rotenone, dinitophenol,
and cyanide inhibit mitochondrial function at well established sites and
are used as tools to study mitochondrial function (9). In
addition, members of the pyrethroid family of insecticides, which were
not discussed above, have recently been found to potent inhibitors of mitochondrial
complex I (12), the same target as the chemical MPP+ which induces
Parkinson's-like symptoms in humans (10).
Figure 6. Mitochondrial Electron Transport
ALTERATIONS IN CYTOCHROME P450
MONOOXYGENASES
The cytochrome P450 monooxygenase
(CYP) enzymes are the major enzymes involved in the initial phase (phase
I) of xenobiotic metabolism (4), often referred to as biotransformation
to distinguish it from intermediary (energy) metabolism. CYPs generally
oxidize xenobiotics (Fig. 7), by hydroxylation for example, which often
renders them substrates for conjugation reactions with large hydrophilic
metabolites and, ultimately, promotes excretion in the urine. Importantly,
however, biotransformation by CYPs can increase as well as decrease the
toxicity of a foreign substance (4). Furthermore, although
the physiological role of these enzymes is unclear, they may be important
for removal of endogenous toxic compounds that are generated during normal
cellular metabolism. Many pesticides including organochlorines and
organophosphorous compounds have been shown to inhibit the activity and/or
alter the expression of various CYP isoforms (13). For example,
parathion inactivates the CYP3A4 isoform during its oxidative biotransformation
(14). These changes may increase the sensitivity of cells
to reactive endogenous metabolites or other xenobiotics (4).
Thus, it has been postulated that inhibition of CYP activity by organophosphorous
compounds could contribute to the development of Parkinson's disease by
rendering neurons more sensitive to toxic metabolites of neurotransmitters
that are normally metabolized by CYP (1)
Figure 7: Hydroxylation of a Substrate by Cytochrome P450 Monooxygenase
DISRUPTION OF HORMONE BALANCE
Hormones play a central role in regulating
the growth and reproductive function of organisms. There is growing
concern that exposure to some chlorinated hydrocarbons such as DTT may
affect hormone balance and increase the risk for cancers and reproductive
dysfunction. For example, O', P'-DDT, which comprises up to 20% of
technical DDT, has been found to compete with the female hormone estradiol
for binding to estrogen receptors (3). Environmental chemicals
that may perturb hormonal (endocrine) systems have been termed endocrine
disrupters.
SUMMARY
Traditional insecticides have targeted
nervous system functions that are common to a wide range of species.
The use of these insecticides has been associated with the killing of beneficial
insects and a risk of toxicity to animals and humans from environmental
exposures. Bisacylhydrazine compounds display highly selective insecticidal
activity by exploiting subtle differences in the hormonal regulation of
insect growth. The novel mechanism of action of these compounds has
identified a promising new direction in the development of insecticides
that should continue to result in chemicals which have less impact on the
environment and are presumably safer to humans.
However, the possible relationships between xenobiotics and human disease
are very complex. Biochemical changes underlying acute toxicity may
be wholly different from more subtle changes that are increasingly recognized
as relevant to long-term health. Acute and short-term animal toxicity
testing may be grossly inadequate at predicting the long-term impact of
chemical exposure on human health. Thus, the continued advancement
towards more selective and safer insecticides may be expedited by a combination
of 1) targeting insect physiology and 2) screening the effects of candidate
compounds on the subcellular processes that are related to human health
and disease.
QUESTIONS
1. Distinguish between excitatory and inhibitory
neurotransmitters. List the ways by which a xenobiotic might produce
acute excitotoxicity. How do lindane and the cyclodiene insecticides
produce excitotoxicity?
2. Where is the primary site of insecticidal action of DTT? What factor is believed to account for the greater toxicity of DTT to fish than to mammals?
3. What role does biotransformation play in the acute sensitivities of an organism to organophosphorous insecticides?
4. Are repeated exposures of a crop worker to subtoxic levels of carbamate or organophosphorous insecticides over the course of one to two weeks more likely to result in symptoms of acetylcholine toxicity? Explain.
5. What two characteristics of the bisacylhydrazine insecticides are considered to underlie the ability of these insecticides to induce a lethal molt?
6. Give two reasons why inhibiting mitochondrial electron transport can produce cellular toxicity.
7. How might differences in the levels and activity
of cytochrome P450 monooxygenase be involved in the sensitivity to insecticides?
REFERENCES
1. Le Couteur, D.G., McLean, A.J., Taylor, M.C.,
Woodham, B.L., and Board, P.G. (1999) Pesticides and Parkinson's
disease. Biomed. Pharmacother.
53, 122-130.
2. Taylor, P. and Brown, J.H. (1994) Acetylcholine.
In Basic Neurochemistry 5th ed. (Siegel, G.J., Agranoff, B.W.,
Albers, R.W., and Molinoff, P.B.,
Eds.) pp 231-260, Raven Press, New York.
3. Crosby, D.G. (1998) Environmental Toxicology and Chemistry, Oxford University Press, New York.
4. Timbrell, J. (2000) Principles of Biochemical Toxicology 3rd ed., Taylor & Francis, London.
5. Dhadialla, T.S., Carlson, G.R., and Le, D.P. (1998)
New insecticides with ecdysteroidal and juvenile hormone activity.
Annu. Rev. Entomol. 43,
545-569.
6. Wing, K.D. (1988) RH 5849, a nonsteroidal ecdysone agonist: effects on a drosophila cell line. Science 241, 467-469.
7. Wing, K.D., Slawecki, R.A., and Carlson, G.R. (1988)
RH 5849, a nonsteroidal ecdysone agonist: effects on larval
Lepidoptera. Science
241, 470-472.
8. Salgado, V.L. (1998) Block of neuronal voltage-dependent
K+ channels by diacylhydrazine insecticides.
Neurotoxicology 19,
245-252.
9. Nelson, D.L., and Cox, M.M. (2000) Lehninger Principles of Biochemistry 3rd ed., Worth Publishers, New York.
10. Beal, M.F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
11. Carlson, K., and Ehrich, M. (1999) Organophosphorous
compound-induced modification of SH-SY5Y human
neuroblastoma mitochondrial
transmembrane potential. Toxicol. Appl. Pharmacol. 160, 33-42.
12. Gassner, B., Wuthrich, A., Scholtysik, G., and Solioz,
M. (1997) The pyrethroids permethrin and cyhalothrin are potent
inhibitors of the
mitochondrial complex I. J. Pharmacol. Exp. Ther. 281, 855-860.
13. Hodgson, E., and Levi, P.E. (1996) Pesticides: an important
but underused model for the environmental health sciences.
Environ. Health Perspect.104,
97-106.
14. Butler, A.M., and Murray, M. (1997) Biotransformation
of parathion in human liver: participation of CYP3A4 and its
inactivation during microsomal
parathion oxidation. J. Pharmacol. Exp. Ther. 280, 966-973.